MRNA Today - Aug 09: FDA Flu Vaccine Approval

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

MRNA Today - Aug 09: FDA Flu Vaccine Approval

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly neighborhood investor. I’ve been in the game for a while, and today we’re chatting about Moderna, ticker MRNA. Spoiler alert: it was a green day for them, up almost 10%! Nice little jump.

So, what went down? Moderna's stock had a solid day, shooting up thanks to some FDA news. They just snagged approval for their flu vaccine, which is a pretty big deal. Everyone's buzzing about it, and that excitement definitely translated to the stock price. People are feeling good about the potential there.

Now, why the hype? Well, the FDA giving the thumbs-up means Moderna's flu shot is officially ready for action. It’s like getting a gold star, you know? Plus, there’s chatter about how this could boost their bottom line, especially since they’re also working on other mRNA vaccines. It’s all about that positive momentum. On top of that, there’s some movement with stock sales from their CEO, which might have spiced things up a little, but honestly, that’s just typical stock market stuff.

Oh, and here’s a quick heads-up: while the flu vaccine approval is great, there's still some uncertainty. They’re waiting on recommendations from the CDC, so that’ll be something to keep an eye on.

To wrap it up, Moderna had a great day with that FDA approval giving them a nice boost. It’s always exciting to see how these developments play out in the market. Just remember, I’m here to share the info and keep it fun, not to give any financial advice. Catch you later!

まだレビューはありません